Substance Use Disorders: A Comprehensive Review and Update 2022

February 20, 2022 to February 23, 2022

Join us for this virtual conference!

A message from our course directors...

Attend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.

Substance use disorders are complex and have a huge impact on patients, families and communities They challenge even experienced health care professionals to stay current with evolving guidelines. And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.

That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.

Pricing

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 16, 2022 Super Early Bird discount extended through January 24, 2022): $595.00
Early Bird Registration (on or before January 30, 2022): $695.00
Regular Registration (after January 30, 2022): $795.00

Other Professionals or Trainees
Super Early Bird Registration (on or before January 16, 2022 Super Early Bird discount extended through January 24, 2022): $495.00
Early Bird Registration (on or before January 30, 2022): $595.00
Regular Registration (after January 30, 2022): $695.00

Sunday, February 20, 2022
Buprenorphine Waiver Training: $50
This is a ticketed event, NO CME CREDIT

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.***

Syllabus

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by January 30, 2022. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

PCSS website link: www.pcssNOW.org
Contact information: pcss@aaap.org
AAAP is the DATA 2000 sponsor for this training.

Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition

Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.

Purchase a print copy of our Board Preparation book here!

Target Audience

This program is intended for:

General and Family Physicians
Psychiatrists
Nurse Practitioners
Physician Assistants
Nurses
Psychologists
Social Workers

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

Describe the best practices for treatment of substance use disorders
Discuss how to properly screen and diagnose substance use disorders
List rational, evidence based pharmacologic and non-pharmacologic therapies for patients with substance use disorders
Assess relative utility and strengths of recovery oriented models of care
Assess and treat patients with co-morbid substance use, mood disorders, anxiety disorders, ADHD, pain, and infectious diseases.
Discuss how to manage complicated withdrawal
Utilize motivational interviewing, CBT and contingency management techniques when working with patients suffering from substance use disorders
Describe the effects of and interventions for marijuana and synthetics
List the different approaches and challenges associated with opioid, alcohol and nicotine treatment
Discuss the challenges associated with identification and management of substance use disorders in the emergency department

Course summary

Available credit:

17.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 17.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
17.75 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 17.75 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
17.50 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 17.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90787-1
17.75 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
17.75 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 17.75 Continuing Education (CE) credits per presentation for psychologists.

Registration opens:

09/01/2021

Course closes:

03/10/2023

Event starts:

02/20/2022 - 8:00am EST

Event ends:

02/23/2022 - 3:50pm EST

Cost:

$795.00

Add to calendar:

Rating:

Substance Use Disorders: A Comprehensive Review and Update

February 20 – 23, 2022

PROGRAM AGENDA

SUNDAY, FEBRUARY 20, 2022

2:00 – 6:00 PM Buprenorphine (MAT) Waiver Training

Laura G. Kehoe, MD, MPH, FASAM

THIS IS A TICKETED EVENT, NO CME CREDIT

MONDAY, FEBRUARY 21, 2022

8:00 – 8:10 AM Welcome & Introduction

David H. Rubin, MD

MODULE TOPIC 1: TREATMENT IN CONTINUING CARE

8:10 – 8:30 AM Motivational Interviewing

John F. Kelly, PhD

8:30 – 8:50 AM CBT

John F. Kelly, PhD

8:50 – 9:10 AM Helping Family Members

John F. Kelly, PhD

9:10 – 9:30 AM Screening Assessment & Patient Monitoring

Eugene Lambert, MD

9:30 – 10:10 AM Panel Discussion

Moderator: Timothy E. Wilens, MD

Panelists: John F. Kelly, PhD, Eugene Lambert, MD

10:10 – 10:30 AM Break

MODULE TOPIC 2: NEUROSCIENCE

10:30– 10:50 AM Neurobiology of Addiction

Timothy E. Wilens, MD

10:50 - 11:10 AM Genetics of Substance Use Disorders

Robert R. Althoff, MD, PhD

11:10 – 11:30 AM Evolutionary Theories of Substance Use

David H. Rubin, MD

MODULE TOPIC 3: GENERAL PRINCIPLES & CARE DELIVERY

11:30 – 11:50 AM Treating Addiction as a Chronic Disease

Jessica Gray, MD

11:50 – 12:10 PM Harm Reduction

Dinah Applewhite, MD

12:10 – 12:30 PM Emergency Room Assessment of Addiction

Dawn Williamson, RN

12:30 – 1:10 PM Panel Discussion

Moderator: John F. Kelly, PhD

Panelists: Jessica Gray, MD, Dinah Applewhite, MD, Dawn Williamson, RN

1:10 – 2:10 PM Lunch Break

MODULE TOPIC 4: OPIOID

2:10 – 2:30 PM Buprenorphine 101

Laura G. Kehoe, MD, MPH, FASAM

2:30 – 2:50 PM Buprenorphine Microdosing and Extended Release

Evan Gale, MD

2:50 – 3:10 PM Naltrexone Intramuscular & Methadone

Evan Gale, MD

3:10 – 3:30 PM Pain

Jessica Gray, MD

3:30 – 3:50 PM Pregnancy

Jessica Gray, MD

3:50 – 4:30 PM Panel Discussion

Moderator: Timothy E. Wilens, MD

Panelists: Eval Gale, MD, Jessica Gray, MD,

Laura G. Kehoe, MD, MPH, FASAM

4:30 PM Adjourn

TUESDAY, FEBRUARY 22, 2022

8:00 – 8:10 AM Introduction

Timothy E. Wilens, MD

MODULE TOPIC 5: Marijuana and Synthetics

8:10 – 8:30 AM Marijuana 101

Timothy E. Wilens, MD

8:30 – 8:50 AM Clinical Management

Robert R. Althoff, MD, PhD

8:50 – 9:10 AM Synthetics, Kratom & Designer Drugs

Timothy E. Wilens, MD

9:10 – 9:50 AM Panel Discussion

Moderator: David H. Rubin, MD

Panelists: Timothy E. Wilens, MD, Robert R. Althoff, MD, PhD

9:50 – 10:10 AM Break

MODULE TOPIC 6: Stimulants

10:10 – 10:30 AM Methamphetamine
Timothy E. Wilens, MD

10:30 – 10:50 AM Cocaine, Rx Stimulants
Timothy E. Wilens, MD

10:50 – 11:30 PM Panel Discussion
Moderator: Timothy E. Wilens, MD

11:30-12:30 PM Lunch Break

MODULE TOPIC 7: Polysubstance Use

12:30 – 12:50 PM Fundamentals of Polysubstance Use
Timothy E. Wilens, MD

12:50 – 1:10 PM Polysubstance Use Cases
Laura G. Kehoe, MD, MPH, FASAM

1:10 – 1:50 PM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Timothy E. Wilens, MD, Laura G. Kehoe, MD, MPH, FASAM

1:50-2:10 PM Break

MODULE TOPIC 8: PHARMACOTHERAPY I

2:10 - 2:30 PM Alcohol

Vinod Rao, MD, PhD

2:30 – 2:50 PM Alcohol Part II

Vinod Rao, MD, PhD

2:50 – 3:30 PM Panel Discussion

Moderator: Timothy E. Wilens, MD

Panelists: Vinod Rao, MD, PhD

3:30 PM Adjourn

WEDNESDAY, FEBRUARY 23, 2022

8:00 – 8:10 AM Introduction

David H. Rubin, MD

MODULE TOPIC 9: SEDATIVES AND NICOTINE

8:10 – 8:30 AM Sedatives and Hypnotics

Robert R. Althoff, MD, PhD

8:30 – 8:50 AM Trends in Adolescent Nicotine Use

Randi Schuster, PhD

8:50 – 9:30 AM Panel Discussion

Moderator: David H. Rubin, MD

Panelists: Randi Schuster, PhD, Robert R. Althoff, MD, PhD

MODULE TOPIC 10: COMORBIDITY

9:30 – 9:50 AM Mood Disorders

Vinod Rao, MD

9:50 – 10:10 AM Trauma

Martha Kane, PhD

10:10 – 10:30 AM Anxiety Disorders

Vinod Rao, MD

10:30 – 11:10 AM Panel Discussion

Moderator: David H. Rubin, MD
Panelists: Martha Kane, PhD, Vinod Rao, MD

11:10 – 11:30 AM Break

MODULE TOPIC 11: RECOVERY SUPPORT SERVICES

11:30 – 11:50 AM Self-Help Treatments

John F. Kelly, PhD

11:50 – 12:10 PM Recovery Coaching & Residences
Martha Kane, PhD

12:10 – 12:30 PM Levels of Care
Martha Kane, PhD

12:30 – 1:10 PM Panel Discussion

Moderator: John F. Kelly, PhD
Panelists: Martha Kane, PhD

1:10 PM Adjourn

Course Director(s)